Infections Clinical Trials

60 recruiting

Infections Trials at a Glance

457 actively recruiting trials for infections are listed on ClinicalTrialsFinder across 6 cities in 78 countries. The largest study group is Not Applicable with 132 trials, with the heaviest enrollment activity in New York, Houston, and Paris. Lead sponsors running infections studies include University Hospital, Strasbourg, France, National Institute of Allergy and Infectious Diseases (NIAID), and ViiV Healthcare.

Treatments under study

About Infections Clinical Trials

Looking for clinical trials for Infections? There are currently 60 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 457 trials

Recruiting

Modeling Host-Pathogen Interaction Using Lymphoid Organoids

Staphylococcal Infections
National Institute of Allergy and Infectious Diseases (NIAID)500 enrolled2 locationsNCT06479837
Recruiting

Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients

AnthraxBacillus Infections
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled1 locationNCT00050310
Recruiting

Diagnosis and Treatment of Leishmania Infections

LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID)289 enrolled1 locationNCT00344188
Recruiting

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

PneumoniaInfectionsImmune System Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT00006150
Recruiting

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Pseudomonas Infections
Centre Hospitalier Régional d'Orléans600 enrolled48 locationsNCT06738771
Recruiting
Phase 2

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

LymphomaEpstein-Barr Virus InfectionsLymphoproliferative Disorder+1 more
National Cancer Institute (NCI)40 enrolled1 locationNCT03258567
Recruiting

In-depth Immunological Investigation of COVID-19.

Coronavirus Infections
Universitaire Ziekenhuizen KU Leuven100 enrolled1 locationNCT04327570
Recruiting

Borrelia B-cell Diagnostics

Lyme DiseaseBorrelia Infections
University Children's Hospital, Zurich502 enrolled1 locationNCT06045416
Recruiting
Not Applicable

Women Focused Encounters for Resilience Independence Strength and Eudaimonia

HIV InfectionsTraumaSubstance Use+1 more
University of California, San Diego300 enrolled1 locationNCT06216600
Recruiting
Not Applicable

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

Community-acquired PneumoniaCommunity-Acquired Infections
Assiut University100 enrolled1 locationNCT06996834
Recruiting
Phase 4

Got Doxy- 'Flipping the Script' on STI PEP

Sexually Transmitted Infections (STI)
Emory University200 enrolled2 locationsNCT07215325
Recruiting
Phase 4

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Staphylococcus Aureus BacteraemiaStaphylococcal Bacteraemia+1 more
Region Skane420 enrolled1 locationNCT06726395
Recruiting

BEYOND Study: Improving HIV Treatment and Well-Being Among Young MSM in Vietnam

HIV InfectionsMental HealthMedication Adherence
Center for Applied Research on Men and Community Health, Vietnam300 enrolled1 locationNCT07559266
Recruiting

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

MortalityPneumococcal InfectionsPneumococcal Conjugate Vaccine+1 more
Association Clinique Thérapeutique Infantile du val de Marne2,500 enrolled1 locationNCT04664556
Recruiting
Phase 3

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

Adenovirus Infections
SymBio Pharmaceuticals180 enrolled61 locationsNCT07387367
Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

ObesityCardiovascular DiseasesChronic Kidney Diseases+8 more
Swiss Tropical & Public Health Institute1,200 enrolled1 locationNCT05881447
Recruiting

Study of Mycobacterial Infections

Mycobacterium Infections
National Institute of Allergy and Infectious Diseases (NIAID)1,000 enrolled1 locationNCT00018044
Recruiting
Phase 3

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting
Not Applicable

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

HIV InfectionsCervix CancerHPV Infection
UNC Lineberger Comprehensive Cancer Center2,912 enrolled1 locationNCT07428330
Recruiting
Not Applicable

The Test-to-PrEP Study

HIV Infections
University of Miami320 enrolled1 locationNCT06927856